Pharmacological preparation for topical use containing N-palmitoyl-vanillamide
The present invention relates to topical preparations containing N-palmitoyl-vanillamide having hyperalgesic activity. In particular, the invention relates to N-palmitoyl-vanillamide for use in the treatment of pathologies selected from: post-herpetic neuralgia, neuralgia of trigeminus, occipital neuralgia, dental neuralgia, glottopharyngeal neuralgia, uremic neuralgia, diabetic neuralgia, headache of different origin, neuropathic itch, neurogenic itch, uremic itch, vulvodinia, vulvar vestibulitis, ano-rectal pain and itch, balano-preputial pain and itch, painful urogenital disorders of dogs and cats, psoriasis-associated pruritus and pain, itching skin diseases (e.g. atopic dermatitis) in the human and veterinary field, muscular pain, pain of the tendon, osteoarthritis associated pain in humans, dogs and cats; painful eye diseases in the human and veterinary field, inflammatory pathologies of the oral cavity in the human and veterinary field.
1. A method for treating or ameliorating hyperalgesia caused by inflammatory or neuropathic conditions in a mammal comprising administering to the mammal a composition which comprises N-palmitoyl-vanillamide and trans-traumatic acid.
2. The method of claim 1 , wherein the mammal is a human.
3. The method of claim 1 , wherein the mammal is a cat or a dog.
4. The method of claim 1 , wherein the inflammatory or neuropathic conditions are selected from the group consisting of: post-herpetic neuralgia, neuralgia of trigeminus, occipital neuralgia, dental neuralgia, glossopharyngeal, neuralgia, headache, uremic neuralgia, diabetic neuralgia, neuropathic itch, neurogenic itch, uremic itch, vulvodynia, vulvar vestibulitis, ano-rectal pain and itch, balanopreputial pain and itch, painful urogenital disorders, psoriasis-associated pruritus and pain, atopic dermatitis, itching skin diseases, muscular pain, pain of a tendon, osteoarthritis-associated pain, painful eye diseases, and inflammatory pathologies of the oral cavity.
5. The method of claim 4 , wherein the inflammatory pathologies of the oral cavity are selected from the group consisting of: gingivitis, periodontitis, stomatitis, post implantation pain, and burning mouth syndrome.
6. The method of claim 4 , wherein the inflammatory pathologies of the oral cavity are selected from the group consisting of: canine and feline gingivitis, periodontitis, gingivostomatitis, and feline resorptive lesions (FORL).
7. The method of claim 1 , wherein the composition is in the form of a topical composition.
8. The method of claim 7 , wherein the topical composition is a cream, gel, lotion, drops for otological application, patch, eyewash, mouthwash or suppository.
9. The method of claim 7 , wherein the composition comprises from about 0.05% to about 5% w/w of N-palmitoyl-vanillamide.